MRSA 300 presenets unique challenges, new treatments

Published: February 18, 2015

Dermatology Times
John Jesitus
Original Article:

Among methicillin-resistant Staphylococcus aureus (MRSA) strains, MRSA 300 is proving particularly widespread and hardy, an expert says. Fortunately, he adds, recently approved intravenous (IV) antibiotics for MRSA require fewer doses than their predecessors.

MRSA 300 has grown particularly problematic in the United States, says Theodore Rosen, M.D., professor of dermatology at Baylor College of Medicine. Typically presenting as abscesses and cellulitis, it is the most common MRSA strain found in the general population, as well as in athletes, soldiers, IV drug users, the homeless and men who have sex with men.

Full text of article available at link below:

Leave a Reply

Your email address will not be published. Required fields are marked *